Seven updates on ultraprocessed foods

Healio’s coverage of research on ultraprocessed foods covers the significant impact these foods have on nutrition and health. Studies have shown a link between ultraprocessed foods and conditions like obesity, cardiovascular disease, depression, and mortality. However, some experts argue that there is not yet enough evidence to support policies against their consumption. The top ultraprocessed…

Read More

Going for a walk wasn’t really a thing 300 years ago—the Victorians turned it into a popular pastime

Walking wasn’t a popular pastime until the late 1700s. The term “pedestrianism” originally had a sporting connotation. It became a leisure activity in the 1780s, popularized by famous walkers such as Charles Dickens and the Lake poets. City streets during the 1800s were dirty and unsanitary, creating jobs for street sweepers and pure finders. These…

Read More

Your unique microbiome may be used to improve and personalize your future medical experience

Researchers discuss using the gut microbiome in personalized medicine. Personalized medicine based on an individual’s gut microflora can overcome limitations of current approaches and provide more accurate diagnostics and treatments. Microbiome analysis has shown promise in diagnostics and treatment of diseases, and AI and machine learning can be used to analyze and predict patient responses…

Read More

What to Expect Over the Long Term

Ulcerative colitis (UC) is a long-term illness characterized by unpredictable symptoms that come and go over time. Around half of Americans with UC are in remission, with three types of remission – clinical, endoscopic, and deep. Deep remission does not mean you are cured, and there is still a chance of future flare-ups. It is…

Read More

FDA Expands Label for CVRx Barostim System in HF

The FDA has approved an expanded label for the Barostim neuromodulation system for patients with heart failure, based on longer-term clinical data from the BeAT-HF trial. The system is indicated for patients with class III or II heart failure with certain criteria. The device stimulates carotid baroreceptors and is implanted below the collarbone. The FDA’s…

Read More

Unbound bilirubin, a robust predictor of acute bilirubin encephalopathy in infants

Unbound bilirubin levels can predict the likelihood of acute bilirubin encephalopathy in infants. This suggests that monitoring unbound bilirubin may help identify infants at risk for this serious condition. The article also mentions the use of cookies for analytics, advertising and site improvement, and directs readers to their Cookie Policy and Settings for more information….

Read More

Cytokinetics Heart Drug’s Trial Data Look Competitive With BMS Med Camzyos

An experimental drug from Cytokinetics has shown promising Phase 3 results in improving heart function during exercise for patients with obstructive hypertrophic cardiomyopathy (oHCM), a rare cardiovascular disease. The drug, aficamten, demonstrated a significant increase in peak oxygen uptake compared to a placebo and had a consistent treatment effect across patient subgroups. The drug works…

Read More
error: Content is protected !!